Roles of TRAFs in NF-κB signaling pathways mediated by BAFF

Immunol Lett. 2018 Apr:196:113-118. doi: 10.1016/j.imlet.2018.01.010. Epub 2018 Feb 20.

Abstract

B cell activating factor (BAFF) is an important cytokine for the maintenance of B cell development, survival and homeostasis. BAFF/BAFF-R could directly activate nuclear factor kappa B (NF-κB) pathway. Tumour necrosis factor receptor-associated factors (TRAFs) are key regulatory proteins in NF-κB signaling pathways. TRAF1 enhances the activation of tumor necrosis factor receptor 2 (TNF-R2) induced by NF-κB. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals mediated by BAFF receptor. TRAF5 is most homologous to TRAF3, as well as most functionally similar to TRAF2. TRAF6 is also required for the BAFF-mediated activation of NF-κB signal pathway. TRAF7 is involved in signal transduction pathways that lead either to activation or repression of NF-κB transcription factor. In this article, we reviewed the roles of TRAFs in NF-κB signaling pathway mediated by BAFF.

Keywords: BAFF; BAFF receptor; NF-κB; Signaling pathways; TRAFs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • B-Cell Activating Factor / immunology*
  • B-Cell Activating Factor / metabolism
  • B-Cell Activation Factor Receptor / immunology
  • B-Cell Activation Factor Receptor / metabolism
  • B-Lymphocytes / immunology
  • B-Lymphocytes / metabolism
  • Cell Survival / immunology
  • Humans
  • Models, Immunological
  • NF-kappa B / immunology*
  • NF-kappa B / metabolism
  • Receptors, Tumor Necrosis Factor, Type II / immunology
  • Receptors, Tumor Necrosis Factor, Type II / metabolism
  • Signal Transduction / immunology*
  • Tumor Necrosis Factor Receptor-Associated Peptides and Proteins / immunology*
  • Tumor Necrosis Factor Receptor-Associated Peptides and Proteins / metabolism

Substances

  • B-Cell Activating Factor
  • B-Cell Activation Factor Receptor
  • NF-kappa B
  • Receptors, Tumor Necrosis Factor, Type II
  • Tumor Necrosis Factor Receptor-Associated Peptides and Proteins